-
1
-
-
84857554191
-
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?
-
Ribeiro J., Macedo L., Curigliano G., Fumagalli L., Locatelli M., Dalton M., et al. Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?. Ann Oncol 2012, 23(3):547-555.
-
(2012)
Ann Oncol
, vol.23
, Issue.3
, pp. 547-555
-
-
Ribeiro, J.1
Macedo, L.2
Curigliano, G.3
Fumagalli, L.4
Locatelli, M.5
Dalton, M.6
-
2
-
-
0036307010
-
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
-
Cardoso F., Di Leo A., Lohrisch C., Bernard C., Ferreira F., Piccart M. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?. Ann Oncol 2002, 13(2):197-207.
-
(2002)
Ann Oncol
, vol.13
, Issue.2
, pp. 197-207
-
-
Cardoso, F.1
Di Leo, A.2
Lohrisch, C.3
Bernard, C.4
Ferreira, F.5
Piccart, M.6
-
3
-
-
67149143399
-
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
-
Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324(5933):1457-1461.
-
(2009)
Science
, vol.324
, Issue.5933
, pp. 1457-1461
-
-
Olive, K.P.1
Jacobetz, M.A.2
Davidson, C.J.3
Gopinathan, A.4
McIntyre, D.5
Honess, D.6
-
4
-
-
67149134933
-
Breaching the cancer fortress
-
Olson P., Hanahan D. Breaching the cancer fortress. Science 2009, 324(5933):1400-1401.
-
(2009)
Science
, vol.324
, Issue.5933
, pp. 1400-1401
-
-
Olson, P.1
Hanahan, D.2
-
5
-
-
0037085376
-
Hyaluronan-cell interactions in cancer and vascular disease
-
Toole B.P., Wight T.N., Tammi M.I. Hyaluronan-cell interactions in cancer and vascular disease. JBiol Chem 2002, 277(7):4593-4596.
-
(2002)
JBiol Chem
, vol.277
, Issue.7
, pp. 4593-4596
-
-
Toole, B.P.1
Wight, T.N.2
Tammi, M.I.3
-
6
-
-
0026674857
-
Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and noninvasive areas
-
Bertrand P., Girard N., Delpech B., Duval C., d'Anjou J., Dauce J. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and noninvasive areas. Int J Cancer 1992, 52(1):1-6.
-
(1992)
Int J Cancer
, vol.52
, Issue.1
, pp. 1-6
-
-
Bertrand, P.1
Girard, N.2
Delpech, B.3
Duval, C.4
d'Anjou, J.5
Dauce, J.6
-
7
-
-
0037325180
-
Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan
-
Wernicke M., Pineiro L.C., Caramutti D., Dorn V.G., Raffo M.M.L., Guixa H.G., et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 2003, 16(2):99-107.
-
(2003)
Mod Pathol
, vol.16
, Issue.2
, pp. 99-107
-
-
Wernicke, M.1
Pineiro, L.C.2
Caramutti, D.3
Dorn, V.G.4
Raffo, M.M.L.5
Guixa, H.G.6
-
8
-
-
0033889231
-
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
-
Auvinen P., Tammi R., Parkkinen J., Tammi M., Ågren U., Johansson R., et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000, 156(2):529.
-
(2000)
Am J Pathol
, vol.156
, Issue.2
, pp. 529
-
-
Auvinen, P.1
Tammi, R.2
Parkkinen, J.3
Tammi, M.4
Ågren, U.5
Johansson, R.6
-
9
-
-
11144355816
-
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
-
Suwiwat S., Ricciardelli C., Tammi R., Tammi M., Auvinen P., Kosma V.M., et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 2004, 10(7):2491-2498.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.7
, pp. 2491-2498
-
-
Suwiwat, S.1
Ricciardelli, C.2
Tammi, R.3
Tammi, M.4
Auvinen, P.5
Kosma, V.M.6
-
10
-
-
40749161146
-
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact
-
Casalini P., Carcangiu M.L., Tammi R., Auvinen P., Kosma V.M., Valagussa P., et al. Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact. Clin Cancer Res 2008, 14(1):25-31.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.1
, pp. 25-31
-
-
Casalini, P.1
Carcangiu, M.L.2
Tammi, R.3
Auvinen, P.4
Kosma, V.M.5
Valagussa, P.6
-
11
-
-
79956352407
-
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors
-
Bollyky P.L., Wu R.P., Falk B.A., Lord J.D., Long S.A., Preisinger A., et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A 2011, 108(19):7938-7943.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.19
, pp. 7938-7943
-
-
Bollyky, P.L.1
Wu, R.P.2
Falk, B.A.3
Lord, J.D.4
Long, S.A.5
Preisinger, A.6
-
12
-
-
78649638780
-
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models
-
Thompson C.B., Shepard H.M., O'Connor P.M., Kadhim S., Jiang P., Osgood R.J., et al. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther 2010, 9(11):3052-3064.
-
(2010)
Mol Cancer Ther
, vol.9
, Issue.11
, pp. 3052-3064
-
-
Thompson, C.B.1
Shepard, H.M.2
O'Connor, P.M.3
Kadhim, S.4
Jiang, P.5
Osgood, R.J.6
-
13
-
-
84865080615
-
The pancreas cancer microenvironment
-
Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment. Clin Cancer Res 2012, 18(16):4266-4276.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.16
, pp. 4266-4276
-
-
Feig, C.1
Gopinathan, A.2
Neesse, A.3
Chan, D.S.4
Cook, N.5
Tuveson, D.A.6
-
14
-
-
77953722864
-
The difficulty of targeting cancer stem cell niches
-
LaBarge M.A. The difficulty of targeting cancer stem cell niches. Clin Cancer Res 2010, 16(12):3121-3129.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.12
, pp. 3121-3129
-
-
LaBarge, M.A.1
-
15
-
-
51249107345
-
Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions
-
Rilla K., Tiihonen R., Kultti A., Tammi M., Tammi R. Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions. JHistochem Cytochem 2008, 56(10):901-910.
-
(2008)
JHistochem Cytochem
, vol.56
, Issue.10
, pp. 901-910
-
-
Rilla, K.1
Tiihonen, R.2
Kultti, A.3
Tammi, M.4
Tammi, R.5
-
16
-
-
50149105712
-
Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
-
Itano N., Zhuo L., Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 2008, 99(9):1720-1725.
-
(2008)
Cancer Sci
, vol.99
, Issue.9
, pp. 1720-1725
-
-
Itano, N.1
Zhuo, L.2
Kimata, K.3
-
17
-
-
77950539395
-
Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts
-
Eikenes L., Tufto I., Schnell E.A., Bjørkøy A., Davies C.D.E.L. Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. Anticancer Res 2010, 30(2):359-368.
-
(2010)
Anticancer Res
, vol.30
, Issue.2
, pp. 359-368
-
-
Eikenes, L.1
Tufto, I.2
Schnell, E.A.3
Bjørkøy, A.4
Davies, C.D.E.L.5
-
18
-
-
34249851948
-
Formation of hyaluronan-and versican-rich pericellular matrix by prostate cancer cells promotes cell motility
-
Ricciardelli C., Russell D.L., Ween M.P., Mayne K., Suwiwat S., Byers S., et al. Formation of hyaluronan-and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. JBiol Chem 2007, 282(14):10814-10825.
-
(2007)
JBiol Chem
, vol.282
, Issue.14
, pp. 10814-10825
-
-
Ricciardelli, C.1
Russell, D.L.2
Ween, M.P.3
Mayne, K.4
Suwiwat, S.5
Byers, S.6
-
19
-
-
0031671794
-
The impact of extracellular matrix on the chemoresistance of solid tumors-experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy
-
Baumgartner G., Gomar-Höss C., Sakr L., Ulsperger E., Wogritsch C. The impact of extracellular matrix on the chemoresistance of solid tumors-experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy. Cancer Lett 1998, 131(1):85-99.
-
(1998)
Cancer Lett
, vol.131
, Issue.1
, pp. 85-99
-
-
Baumgartner, G.1
Gomar-Höss, C.2
Sakr, L.3
Ulsperger, E.4
Wogritsch, C.5
-
20
-
-
0032508620
-
Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner
-
Brekken C., de Lange Davies C. Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner. Cancer Lett 1998, 131(1):65-70.
-
(1998)
Cancer Lett
, vol.131
, Issue.1
, pp. 65-70
-
-
Brekken, C.1
de Lange Davies, C.2
-
21
-
-
52449091656
-
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models
-
Ganesh S., Gonzalez-Edick M., Gibbons D., Van Roey M., Jooss K. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models. Clin Cancer Res 2008, 14(12):3933-3941.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.12
, pp. 3933-3941
-
-
Ganesh, S.1
Gonzalez-Edick, M.2
Gibbons, D.3
Van Roey, M.4
Jooss, K.5
-
22
-
-
84859983619
-
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look
-
Whatcott C.J., Han H., Posner R.G., Hostetter G., Von Hoff D.D. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov 2011, 1(4):291-296.
-
(2011)
Cancer Discov
, vol.1
, Issue.4
, pp. 291-296
-
-
Whatcott, C.J.1
Han, H.2
Posner, R.G.3
Hostetter, G.4
Von Hoff, D.D.5
-
23
-
-
58149269566
-
CD44 is of functional importance for colorectal cancer stem cells
-
Du L., Wang H., He L., Zhang J., Ni B., Wang X., et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008, 14(21):6751-6760.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.21
, pp. 6751-6760
-
-
Du, L.1
Wang, H.2
He, L.3
Zhang, J.4
Ni, B.5
Wang, X.6
-
24
-
-
0032933779
-
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival
-
Kayastha S., Freedman A.N., Piver M.S., Mukkamalla J., Romero-Guittierez M., Werness B.A. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res 1999, 5(5):1073-1076.
-
(1999)
Clin Cancer Res
, vol.5
, Issue.5
, pp. 1073-1076
-
-
Kayastha, S.1
Freedman, A.N.2
Piver, M.S.3
Mukkamalla, J.4
Romero-Guittierez, M.5
Werness, B.A.6
-
25
-
-
34247571007
-
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study
-
Rupp U., Schoendorf-Holland E., Eichbaum M., Schuetz F., Lauschner I., Schmidt P., et al. Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study. Anticancer Drugs 2007, 18(4):477-485.
-
(2007)
Anticancer Drugs
, vol.18
, Issue.4
, pp. 477-485
-
-
Rupp, U.1
Schoendorf-Holland, E.2
Eichbaum, M.3
Schuetz, F.4
Lauschner, I.5
Schmidt, P.6
-
26
-
-
34247890107
-
Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck
-
Sauter A., Kloft C., Gronau S., Bogeschdorfer F., Erhardt T., Golze W., et al. Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck. Int J Oncol 2007, 30(4):927.
-
(2007)
Int J Oncol
, vol.30
, Issue.4
, pp. 927
-
-
Sauter, A.1
Kloft, C.2
Gronau, S.3
Bogeschdorfer, F.4
Erhardt, T.5
Golze, W.6
-
27
-
-
50049134725
-
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
-
Riechelmann H., Sauter A., Golze W., Hanft G., Schroen C., Hoermann K., et al. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol 2008, 44(9):823-829.
-
(2008)
Oral Oncol
, vol.44
, Issue.9
, pp. 823-829
-
-
Riechelmann, H.1
Sauter, A.2
Golze, W.3
Hanft, G.4
Schroen, C.5
Hoermann, K.6
-
28
-
-
41649091787
-
EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44
-
Pályi-Krekk Z., Barok M., Kovács T., Saya H., Nagano O., Szöllosi J., et al. EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44. Cancer Lett 2008, 263(2):231-242.
-
(2008)
Cancer Lett
, vol.263
, Issue.2
, pp. 231-242
-
-
Pályi-Krekk, Z.1
Barok, M.2
Kovács, T.3
Saya, H.4
Nagano, O.5
Szöllosi, J.6
-
29
-
-
35448969823
-
Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer
-
Palyi-Krekk Z., Barok M., Isola J., Tammi M., Szollosi J., Nagy P. Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer. Eur J Cancer 2007, 43(16):2423-2433.
-
(2007)
Eur J Cancer
, vol.43
, Issue.16
, pp. 2423-2433
-
-
Palyi-Krekk, Z.1
Barok, M.2
Isola, J.3
Tammi, M.4
Szollosi, J.5
Nagy, P.6
-
30
-
-
44749090941
-
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells
-
Toole B.P., Slomiany M.G. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 2008, 18:244-250.
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 244-250
-
-
Toole, B.P.1
Slomiany, M.G.2
-
31
-
-
84861130721
-
Hyaluronan regulation of vascular integrity
-
Lennon F.E., Singleton P.A. Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis 2011, 1(3):200-213.
-
(2011)
Am J Cardiovasc Dis
, vol.1
, Issue.3
, pp. 200-213
-
-
Lennon, F.E.1
Singleton, P.A.2
-
32
-
-
84871121656
-
The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering
-
Yang C., Cao M., Liu H., He Y., Xu J., Du Y., et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. JBiol Chem 2012, 287(51):43094-43107.
-
(2012)
JBiol Chem
, vol.287
, Issue.51
, pp. 43094-43107
-
-
Yang, C.1
Cao, M.2
Liu, H.3
He, Y.4
Xu, J.5
Du, Y.6
-
33
-
-
73349134974
-
Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities
-
Toole B.P. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009, 15(24):7462-7468.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.24
, pp. 7462-7468
-
-
Toole, B.P.1
-
34
-
-
77954386652
-
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
-
Rivkin I., Cohen K., Koffler J., Melikhov D., Peer D., Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010, 31(27):7106-7114.
-
(2010)
Biomaterials
, vol.31
, Issue.27
, pp. 7106-7114
-
-
Rivkin, I.1
Cohen, K.2
Koffler, J.3
Melikhov, D.4
Peer, D.5
Margalit, R.6
-
35
-
-
79955761548
-
Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers
-
Bachar G., Cohen K., Hod R., Feinmesser R., Mizrachi A., Shpitzer T., et al. Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers. Biomaterials 2011, 32(21):4840-4848.
-
(2011)
Biomaterials
, vol.32
, Issue.21
, pp. 4840-4848
-
-
Bachar, G.1
Cohen, K.2
Hod, R.3
Feinmesser, R.4
Mizrachi, A.5
Shpitzer, T.6
-
36
-
-
51049098968
-
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor
-
Platt V.M., Szoka F.C. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 2008, 5(4):474-486.
-
(2008)
Mol Pharm
, vol.5
, Issue.4
, pp. 474-486
-
-
Platt, V.M.1
Szoka, F.C.2
-
37
-
-
67449119423
-
Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides
-
Slomiany M.G., Dai L., Bomar P.A., Knackstedt T.J., Kranc D.A., Tolliver L., et al. Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res 2009, 69(12):4992-4998.
-
(2009)
Cancer Res
, vol.69
, Issue.12
, pp. 4992-4998
-
-
Slomiany, M.G.1
Dai, L.2
Bomar, P.A.3
Knackstedt, T.J.4
Kranc, D.A.5
Tolliver, L.6
-
38
-
-
0034282677
-
Hyaluronan binding by cell surface CD44
-
Lesley J., Hascall V.C., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. JBiol Chem 2000, 275(35):26967-26975.
-
(2000)
JBiol Chem
, vol.275
, Issue.35
, pp. 26967-26975
-
-
Lesley, J.1
Hascall, V.C.2
Tammi, M.3
Hyman, R.4
-
39
-
-
33746754750
-
Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study
-
Gao F., Cao M., Yang C., He Y., Liu Y. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. JBiomed Mater Res B 2006, 78(2):385-392.
-
(2006)
JBiomed Mater Res B
, vol.78
, Issue.2
, pp. 385-392
-
-
Gao, F.1
Cao, M.2
Yang, C.3
He, Y.4
Liu, Y.5
-
40
-
-
84864454025
-
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma
-
Lee S.J., Ghosh S.C., Han H.D., Stone R.L., Bottsford-Miller J., Shen de Y., et al. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clin Cancer Res 2012, 18(15):4114-4121.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.15
, pp. 4114-4121
-
-
Lee, S.J.1
Ghosh, S.C.2
Han, H.D.3
Stone, R.L.4
Bottsford-Miller, J.5
Shen de, Y.6
-
41
-
-
50349086791
-
Apaclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent invivo therapeutic activity
-
Banzato A., Bobisse S., Rondina M., Renier D., Bettella F., Esposito G., et al. Apaclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent invivo therapeutic activity. Clin Cancer Res 2008, 14(11):3598-3606.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.11
, pp. 3598-3606
-
-
Banzato, A.1
Bobisse, S.2
Rondina, M.3
Renier, D.4
Bettella, F.5
Esposito, G.6
-
42
-
-
84865713442
-
Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist
-
Weigand S., Herting F., Maisel D., Nopora A., Voss E., Schaab C., et al. Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist. Cancer Res 2012, 72(17):4329-4339.
-
(2012)
Cancer Res
, vol.72
, Issue.17
, pp. 4329-4339
-
-
Weigand, S.1
Herting, F.2
Maisel, D.3
Nopora, A.4
Voss, E.5
Schaab, C.6
-
43
-
-
84871157346
-
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
-
Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., Frese K.K., et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2013, 62:112-120.
-
(2013)
Gut
, vol.62
, pp. 112-120
-
-
Jacobetz, M.A.1
Chan, D.S.2
Neesse, A.3
Bapiro, T.E.4
Cook, N.5
Frese, K.K.6
-
44
-
-
44749083057
-
Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan
-
Tammi R.H., Kultti A., Kosma V.M., Pirinen R., Auvinen P., Tammi M.I. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 2008, 18(4):288-295.
-
(2008)
Semin Cancer Biol
, vol.18
, Issue.4
, pp. 288-295
-
-
Tammi, R.H.1
Kultti, A.2
Kosma, V.M.3
Pirinen, R.4
Auvinen, P.5
Tammi, M.I.6
-
45
-
-
84858602107
-
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
-
Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21(3):418-429.
-
(2012)
Cancer Cell
, vol.21
, Issue.3
, pp. 418-429
-
-
Provenzano, P.P.1
Cuevas, C.2
Chang, A.E.3
Goel, V.K.4
Von Hoff, D.D.5
Hingorani, S.R.6
-
46
-
-
34447258681
-
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize
-
Fukumura D., Jain R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. JCell Biochem 2006, 101(4):937-949.
-
(2006)
JCell Biochem
, vol.101
, Issue.4
, pp. 937-949
-
-
Fukumura, D.1
Jain, R.K.2
-
47
-
-
80052159184
-
Biological hydrogels as selective diffusion barriers
-
Lieleg O., Ribbeck K. Biological hydrogels as selective diffusion barriers. Trends Cell Biol 2011, 21(9):543-551.
-
(2011)
Trends Cell Biol
, vol.21
, Issue.9
, pp. 543-551
-
-
Lieleg, O.1
Ribbeck, K.2
-
48
-
-
19544383942
-
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity
-
Nishida Y., Knudson W., Knudson C.B., Ishiguro N. Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp Cell Res 2005, 307(1):194-203.
-
(2005)
Exp Cell Res
, vol.307
, Issue.1
, pp. 194-203
-
-
Nishida, Y.1
Knudson, W.2
Knudson, C.B.3
Ishiguro, N.4
-
49
-
-
34547680442
-
Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 invitro and invivo via perturbation of hyaluronan-rich pericellular matrix of the cells
-
Hosono K., Nishida Y., Knudson W., Knudson C.B., Naruse T., Suzuki Y., et al. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 invitro and invivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 2007, 171(1):274-286.
-
(2007)
Am J Pathol
, vol.171
, Issue.1
, pp. 274-286
-
-
Hosono, K.1
Nishida, Y.2
Knudson, W.3
Knudson, C.B.4
Naruse, T.5
Suzuki, Y.6
-
50
-
-
41549125075
-
Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors
-
Gilg A.G., Tye S.L., Tolliver L.B., Wheeler W.G., Visconti R.P., Duncan J.D., et al. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin Cancer Res 2008, 14(6):1804-1813.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.6
, pp. 1804-1813
-
-
Gilg, A.G.1
Tye, S.L.2
Tolliver, L.B.3
Wheeler, W.G.4
Visconti, R.P.5
Duncan, J.D.6
-
51
-
-
73349093389
-
Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides
-
Slomiany M.G., Dai L., Tolliver L.B., Grass G.D., Zeng Y., Toole B.P. Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides. Clin Cancer Res 2009, 15(24):7593-7601.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.24
, pp. 7593-7601
-
-
Slomiany, M.G.1
Dai, L.2
Tolliver, L.B.3
Grass, G.D.4
Zeng, Y.5
Toole, B.P.6
|